Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine 1/2

Episode von Medizin - Open Access LMU - Teil 20/22 von Ludwig-Maximilians-Universität München · 1. Juli 2012

To assess the effect of ranibizumab treatment for neovascular age-related macular degeneration (nvAMD) on patients' preferences and vision-related quality of life (VRQoL) in a routine clinical setting.

Weitere Episoden von „Medizin - Open Access LMU - Teil 20/22“

Alle Episoden von Medizin - Open Access LMU - Teil 20/22 · Mehr Bildung-Podcasts